eMedicine Specialties > Infectious Diseases > Viral Infections
Vaccinia: Differential Diagnoses & Workup
Updated: Aug 24, 2006
- Overview
- Differential Diagnoses & Workup
- Treatment & Medication
- Follow-up
- Multimedia
Differential Diagnoses
Erythema Multiforme (Stevens-Johnson
Syndrome)
Gas Gangrene
Impetigo
Other Problems to Be Considered
Pustular impetigo
Roseola
Conjunctivitis
Encephalitis of other causes
Workup
Laboratory Studies
- The diagnosis of vaccinia virus complications usually is straightforward and depends on obtaining the history of recent vaccinia virus exposure by vaccination or contact with a vaccinated individual. A careful workup for immune deficiency should be considered in patients who do not improve promptly.
- The diagnosis of CNS complications is more difficult because the signs and symptoms are nonspecific. Although rare, postvaccinial encephalitis should be considered in any patient with neurologic symptoms developing 1-2 weeks after exposure to live vaccinia virus. Vaccinia virus has not been isolated from cerebrospinal fluid (CSF) of patients with encephalitis, and CSF analysis usually produces normal results, except for increased pressure; however, CSF analysis may be indicated to exclude other causes of encephalitis.
Imaging Studies
- Imaging studies are not useful in the diagnosis of vaccinia infection or a postvaccinial complication, although imaging modalities may be helpful to exclude other causes of disease (eg, MRI of the brain in cases of suspected encephalitis).
Other Tests
- Patients who present with skin manifestations usually have live viral particles replicating in the dermal lesions. The presence of vaccinia virus can be confirmed by obtaining a biopsy of the skin lesion and examination through microscopy, plaque titer assay, Western blot, and polymerase chain reaction (PCR) analysis.
Histologic Findings
Light microscopy may reveal characteristic inclusions (ie, Guarnieri bodies) in the cytoplasm of infected cells. This is distinctive from viruses such as herpes simplex virus (HSV) which usually have intranuclear inclusion bodies.
More on Vaccinia |
| Overview: Vaccinia |
Differential Diagnoses & Workup: Vaccinia |
| Treatment & Medication: Vaccinia |
| Follow-up: Vaccinia |
| Multimedia: Vaccinia |
| References |
| « Previous Page | Next Page » |
References
Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. Apr 25 2002;346(17):1300-8. [Medline].
Buller RM, Palumbo GJ. Poxvirus pathogenesis. Microbiol Rev. Mar 1991;55(1):80-122. [Medline].
Carroll MW, Moss B. Poxviruses as expression vectors. Curr Opin Biotechnol. Oct 1997;8(5):573-7. [Medline].
Casey CG, Iskander JK, Roper MH, et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA. Dec 7 2005;294(21):2734-43.
Damon I. Orthopoxviruses: Vaccinia (Smallpox Vaccine), Variola (Smallpox), Monkeypox, and Cowpox. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 6th ed. Orlando, FL:. Churchill Livingstone;2005:1742-1755.
Friedman HM. Smallpox, Vaccinia, and Other Poxviruses. In: Isselbacher, et al, eds. Harrison's Principles of Internal Medicine. 13th ed. New York, NY:. McGraw-Hill;1994:798-799.
Grabenstein JD, Winkenwerder W. US military smallpox vaccination program experience. JAMA. Jun 25 2003;289(24):3278-82.
Haga IR, Bowie AG. Evasion of innate immunity by vaccinia virus. Parasitology. 2005;130 Suppl:S11-25.
Harrop R, Ryan MG, Golding H, et al. Monitoring of human immunological responses to vaccinia virus. Methods Mol Biol. 2004;269:243-66.
Hopkins RJ, Lane JM. Clinical efficacy of intramuscular vaccinia immune globulin: a literature review. Clin Infect Dis. Sep 15 2004;39(6):819-26. [Medline].
Lane HC, Fauci AS. Microbial bioterrorism In: Kasper, et al, eds. Harrison's Principles of Internal Medicine. 16th ed. New York, NY:. McGraw-Hill;2005.
Lane JM, Millar JD. Risks of smallpox vaccination complications in the United States. Am J Epidemiol. Apr 1971;93(4):238-40. [Medline].
Lewis FS, Norton SA, Bradshaw RD, et al. Analysis of cases reported as generalized vaccinia during the US military smallpox vaccination program, December 2002 to December 2004. J Am Acad Dermatol. Jul 2006;55(1):23-31.
Moss B. Vaccinia virus: a tool for research and vaccine development. Science. Jun 21 1991;252(5013):1662-7. [Medline].
Moss B. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc Natl Acad Sci U S A. Oct 15 1996;93(21):11341-8. [Medline].
Moss B. Poxvirus entry and membrane fusion. Virology. Jan 5 2006;344(1):48-54.
Neff JM. Vaccinia Virus (Cowpox). In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa:. Churchill Livingstone;2000:1553-1555.
Paoletti E. Applications of pox virus vectors to vaccination: an update. Proc Natl Acad Sci U S A. Oct 15 1996;93(21):11349-53. [Medline].
Redfield RR, Wright DC, James WD. Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease. N Engl J Med. Mar 12 1987;316(11):673-6. [Medline].
Savona MR, Dela Cruz WP, Jones MS, et al. Detection of vaccinia DNA in the blood following smallpox vaccination. JAMA. Apr 26 2006;295(16):1898-900.
Sejvar JJ, Labutta RJ, Chapman LE, et al. Neurologic adverse events associated with smallpox vaccination in the United States, 2002-2004. JAMA. Dec 7 2005;294(21):2744-50.
Sepkowitz KA. How contagious is vaccinia?. N Engl J Med. Jan 30 2003;348(5):439-46.
Stark JH, Frey SE, Blum PS, Monath TP. Lack of transmission of vaccinia virus. Emerg Infect Dis. Apr 2006;12(4):698-700.
Further Reading
Keywords
vaccinia, vaccinia virus, smallpox, variola, cowpox, poxviruses, Poxviridae, vaccinia necrosum, eczema vaccinatum, vaccinia immune globulin, VIG, orthopoxvirus
Differential Diagnoses & Workup: Vaccinia